tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

CRNX Stock Latest News

Crinetics gets EMA approval for paltusotine marketing authorization application
The FlyCrinetics gets EMA approval for paltusotine marketing authorization application
7d ago
CRNX
Crinetics initiated with a Buy at Stifel
PremiumThe Fly
Crinetics initiated with a Buy at Stifel
9d ago
CRNX
Promising Pipeline and Strategic Initiatives Drive Buy Rating for Crinetics Pharmaceuticals
PremiumRatings
Promising Pipeline and Strategic Initiatives Drive Buy Rating for Crinetics Pharmaceuticals
27d ago
CRNX
Crinetics Pharma’s Earnings Call: Progress Amid Challenges
PremiumCompany Announcements
Crinetics Pharma’s Earnings Call: Progress Amid Challenges
1M ago
CRNX
Crinetics Pharmaceuticals: Promising Transition to Commercialization Amidst Safety Concerns and Strategic Market Positioning
PremiumRatings
Crinetics Pharmaceuticals: Promising Transition to Commercialization Amidst Safety Concerns and Strategic Market Positioning
1M ago
CRNX
Crinetics Pharmaceuticals: Promising Developments and Strategic Initiatives Underpin Buy Rating
PremiumRatingsCrinetics Pharmaceuticals: Promising Developments and Strategic Initiatives Underpin Buy Rating
1M ago
CRNX
Crinetics price target lowered to $91 from $92 at Citizens JMP
Premium
The Fly
Crinetics price target lowered to $91 from $92 at Citizens JMP
1M ago
CRNX
Crinetics Pharmaceuticals: Buy Rating Backed by Promising Pipeline and Strategic Growth Plans
Premium
Ratings
Crinetics Pharmaceuticals: Buy Rating Backed by Promising Pipeline and Strategic Growth Plans
1M ago
CRNX
Crinetics price target lowered to $68 from $74 at Citi
PremiumThe Fly
Crinetics price target lowered to $68 from $74 at Citi
1M ago
CRNX
Crinetics Pharmaceuticals: Promising Future with Paltusotine Launch and Robust Pipeline Development
PremiumRatings
Crinetics Pharmaceuticals: Promising Future with Paltusotine Launch and Robust Pipeline Development
1M ago
CRNX
Crinetics Pharmaceuticals: Positioned for Growth with Promising Drug Pipeline and Strong Financials
PremiumRatings
Crinetics Pharmaceuticals: Positioned for Growth with Promising Drug Pipeline and Strong Financials
1M ago
CRNX
Crinetics Pharmaceuticals: Financial Results and Future Plans
PremiumCompany Announcements
Crinetics Pharmaceuticals: Financial Results and Future Plans
1M ago
CRNX
Crinetics reports Q4 EPS (88c), consensus (89c)
PremiumThe FlyCrinetics reports Q4 EPS (88c), consensus (89c)
1M ago
CRNX
Crinetics Pharmaceuticals Appoints New Chief Financial Officer
Premium
Company Announcements
Crinetics Pharmaceuticals Appoints New Chief Financial Officer
1M ago
8K
CRNX
Crinetics appoints Tobin Schilke as CFO
Premium
The Fly
Crinetics appoints Tobin Schilke as CFO
1M ago
CRNX
Crinetics initiated with a Buy at TD Cowen
PremiumThe Fly
Crinetics initiated with a Buy at TD Cowen
2M ago
CRNX
Crinetics Pharmaceuticals: Strategic Buy Opportunity Amid Pipeline Advancements and Market Undervaluation
PremiumRatings
Crinetics Pharmaceuticals: Strategic Buy Opportunity Amid Pipeline Advancements and Market Undervaluation
2M ago
CRNX
Wolfe starts Crinetics at Peer Perform, believes hedge funds turning bearish
PremiumThe Fly
Wolfe starts Crinetics at Peer Perform, believes hedge funds turning bearish
2M ago
CRNX
Crinetics initiated with a Peer Perform at Wolfe Research
PremiumThe Fly
Crinetics initiated with a Peer Perform at Wolfe Research
2M ago
CRNX
Crinetics upgraded to Buy from Hold at Jefferies
PremiumThe FlyCrinetics upgraded to Buy from Hold at Jefferies
2M ago
CRNX
Crinetics Pharmaceuticals Outlines 2025 Strategic Priorities
Premium
Company Announcements
Crinetics Pharmaceuticals Outlines 2025 Strategic Priorities
3M ago
8K
CRNX
Crinetics data ‘compelling’ despite safety concerns, says Leerink
Premium
The Fly
Crinetics data ‘compelling’ despite safety concerns, says Leerink
3M ago
CRNX

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >